Fitzsimon_menu

Find out what's happening on campus and across the industry.

Read Fitzsimons Innovation Community news, industry highlights, editorials, and innovation updates happening weekly on our campus.

CREJ: Fitzsimmons and CBRE: A Market Outlook for 2025 and Beyond
News | Apr 21, 2025

CREJ: Fitzsimmons and CBRE: A Market Outlook for 2025 and Beyond

Each quarter the Colorado Real Estate Journal publishes its Healthcare and Life Sciences Quarterly to report on the state of commercial real estate in Colorado. The most recent edition includes an article from Fitzsimons and our leasing partners at CBRE to explore the forecast for life sciences real estate markets in our region, and why Fitzsimons is uniquely positioned to welcome new life sciences companies to our supportive campus.

Aurora Now Interviews Kelly Brough About Fitzsimons' Momentum
News | Apr 16, 2025

Aurora Now Interviews Kelly Brough About Fitzsimons' Momentum

Aurora's Fitzsimons Innovation Community is saving lives, literally! It's home to all kinds of cutting-edge life science companies that are coming up with ways to improve medical technology and patient care. AuroraTV talks with Fitzsimons' new President and CEO, Kelly Brough, about what lies ahead.

Fitzsimons and CBRE Market Outlook
Blog | Apr 16, 2025

Fitzsimons and CBRE Market Outlook

We had the pleasure of speaking with David Saad, CBRE Executive Vice President who runs their life sciences group here in Denver. We’re excited to have him walk us through CBRE's annual 2025 Life Sciences Outlook and provide insight into how it pertains to the Colorado market and what the future of life sciences real estate looks like in the Denver-Boulder-Aurora region, and specifically on the Fitzsimons Innovation Community campus.

Melissa Krebs Inducted Into American Institute for Medical and Biological Engineering College of Fellows
News | Apr 14, 2025

Melissa Krebs Inducted Into American Institute for Medical and Biological Engineering College of Fellows

Melissa Krebs, Ph.D., CEO and Founder of Community member GelSana, has been inducted into the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows. ​This prestigious honor recognizes her pioneering advancements in cell-interactive biomaterials and their clinical translation, particularly in regenerative medicine and drug delivery technologies. Her innovative work is making significant strides in improving patient outcomes and quality of life.

RefinedScience Completes Office and Lab Buildout
News | Apr 07, 2025

RefinedScience Completes Office and Lab Buildout

BNBuilders announced the completion of a new 5,500-square-foot office and lab space for RefinedScience at the Fitzsimons Innovation Community Campus. This modern, functional environment is designed to support scientific innovation and enhance collaboration.

Groundbreaking Results from CPC Clinical Research-led STRIDE Trial
News | Apr 03, 2025

Groundbreaking Results from CPC Clinical Research-led STRIDE Trial

This Phase 3b trial suggests that semaglutide 1.0 mg (Ozempic) could become the first therapy in nearly 20 years to gain regulatory approval for improving functional outcomes in patients with peripheral artery disease (PAD) and type 2 diabetes (T2D). sciences real estate markets in our region, and why Fitzsimons is uniquely positioned to welcome new life sciences companies to our supportive campus.

Aurora coffee shop offers job training for people experiencing homelessness
News | Apr 02, 2025

Aurora coffee shop offers job training for people experiencing homelessness

Change Please Coffee at Fitzsimons Innovation Community in Aurora is a coffee shop that is doing good in the community by helping people get back on their feet.

RheumaGen:Tackling Autoimmune Disease with Cell and Gene Therapy
News | Apr 01, 2025

RheumaGen:Tackling Autoimmune Disease with Cell and Gene Therapy

Inside Precision Medicine recently highlighted Community member RheumaGen's mission to develop one-time, curative CGT treatments for autoimmune diseases. Read more about their innovative approach and hear from Co-founder and CEO, Richard Freed.